Even more interesting, in LCTA, a higher percentage of patients with lymph node metastatic tissues (83–100%) showed lower expression of Cdh23 than lung SCC (LUSC; 66.6%) and AD (73.3%). The gene discussed is CDH23; the disease is Alzheimer disease.